Straumann and Nobel Biocare settle patent dispute

Search Dental Tribune

Straumann and Nobel Biocare settle patent dispute

Straumann recently announced that it has won a patent lawsuit filed by Nobel Biocare against the company. (Photograph: designer491/Shutterstock)

By Straumann

Tue. 8. January 2019


BASEL, Switzerland: Straumann recently announced that the company has settled its long-running patent dispute against Nobel Biocare in the US.

The dispute began in 2014 and involved an early version of the Neodent Drive CM implant, which was superseded soon afterwards. Nobel Biocare claimed that the version in question infringed two of its patents, but Straumann successfully challenged one of them at the US Patent Trial and Appeal Board. The ruling, which invalidated a patent on a key feature of the NobelActive implant, was recently upheld—despite Nobel Biocare’s subsequent appeal to the US Court of Appeals for the Federal Circuit. Nobel Biocare has now agreed to take no further action regarding the decision and to dismiss its pending court action.

“We are delighted with this outcome” said Dr Andreas Meier, General Counsel of Straumann. “Neodent’s new GM implant range is unchallenged and we are not required to pay any compensation.”

Dental implant NobelActive Patent

Leave a Reply

Your email address will not be published. Required fields are marked *